Last €66.33 EUR
Change Today +0.076 / 0.11%
Volume 50.0
VEN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 7:59 AM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

ventas inc (VEN) Snapshot

Open
€66.06
Previous Close
€66.25
Day High
€67.48
Day Low
€66.03
52 Week High
01/26/15 - €72.40
52 Week Low
03/20/14 - €42.39
Market Cap
21.9B
Average Volume 10 Days
12.9
EPS TTM
--
Shares Outstanding
330.8M
EX-Date
03/4/15
P/E TM
--
Dividend
€2.31
Dividend Yield
2.87%
Current Stock Chart for VENTAS INC (VEN)

ventas inc (VEN) Related Businessweek News

No Related Businessweek News Found

ventas inc (VEN) Details

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The firm primarily invests in healthcare-related facilities including hospitals, skilled nursing facilities, senior housing facilities, medical office buildings, and other healthcare related facilities. Ventas, Inc. was founded in 1983 and is based in Chicago, Illinois with additional offices in Irvine, California; Louisville, Kentucky; Charlotte, North Carolina; and Dallas, Texas.

479 Employees
Last Reported Date: 02/13/15
Founded in 1983

ventas inc (VEN) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $1.0M
President
Total Annual Compensation: $618.0K
Executive Vice President of Medical Property ...
Total Annual Compensation: $412.0K
Chief Administrative Officer, Executive Vice ...
Total Annual Compensation: $463.5K
Compensation as of Fiscal Year 2013.

ventas inc (VEN) Key Developments

Ventas, Inc. Declares Second Installment of the First Quarter of 2015, Payable on March 31, 2015; Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Earnings Guidance for 2015

Ventas, Inc.'s board of directors declared the second installment of the first quarter 2015 dividend on the company's common stock in the amount of $0.5793 per share, payable in cash on March 31, 2015 to stockholders of record on March 6, 2015. On January 27, 2015, the company paid the first installment of its first quarter 2015 dividend in the amount of $0.2107 to stockholders of record on January 15, 2015, in connection with the company's acquisition of HCT. Together, these two installments total to the company's regular quarterly dividend of $0.79 per share and represent a 9% increase from the dividend in the first quarter of 2014. The company announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported income from loans and investments of $15,734,000 against $12,924,000 a year ago. Total revenues were $803,987,000 against $733,185,000 a year ago. Income before loss from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and non-controlling interest was $93,736,000 against $111,087,000 a year ago. Income from continuing operations was $106,600,000 or $0.36 per diluted share against $108,774,000 or $0.37 per diluted share a year ago. Net income attributable to common stockholders was $107,190,000 or $0.36 per diluted share against $108,440,000 or $0.37 per diluted share a year ago. Net cash provided by operating activities was $334,873,000 against $359,326,000 a year ago. Capital expenditures were $31,219,000 against $30,980,000 a year ago. Normalized FFO increased 9% to $342.2 million, from $313.6 million for the comparable 2013 period. Normalized FFO per diluted common share was $1.15 grew 8.5% against $1.06 in the fourth quarter of 2013. Normalized FFO increase is primarily due to the positive impact of acquisitions together with the strong performance of same-store portfolio in the quarter. For the year, the company reported income from loans and investments of $55,169,000 against $58,208,000 a year ago. Total revenues were $3,075,746,000 against $2,811,452,000 a year ago. Income before loss from unconsolidated entities, income taxes, discontinued operations, real estate dispositions and non-controlling interest was $448,517,000 against $479,848,000 a year ago. Income from continuing operations was $457,110,000 or $1.59 per diluted share against $491,168,000 or $1.66 per diluted share a year ago. Net income attributable to common stockholders was $475,767,000 or $1.60 per diluted share against $453,509,000 or $1.54 per diluted share a year ago. Net cash provided by operating activities was $1,254,845,000 against $1,194,755,000 a year ago. Capital expenditures were $87,454,000 against $81,614,000 a year ago. Normalized FFO was $1,330,018,000 against $1,220,709,000 a year ago. Normalized FFO per diluted common share was $4.48 against $4.14 a year ago. This increase is driven by the full year carryover impact of acquisitions completed in 2013 together with $2.4 billion of new investments in 2014. 2015 NAREIT FFO per diluted share to range between $4.55 and $4.66 and normalized FFO per diluted share to range between $4.63 and $4.71. The company’s investments closed year to date, including HCT, are included in the guidance. Same-store cash NOI is forecast to grow 2.5 to 3.5% in 2015. The Company’s guidance assumes over $600 million in property dispositions and receipt of loan repayments, expected mostly in the first quarter of 2015, with later year reinvestment of net proceeds. No further investment or disposition activity, other than the capital recycling forecast in the prior sentence, is included in this targeted range.

Ventas, Inc. Presents at Citl's 2015 Global Property CEO Conference, Mar-03-2015 08:50 AM

Ventas, Inc. Presents at Citl's 2015 Global Property CEO Conference, Mar-03-2015 08:50 AM. Venue: The Diplomat Resort & Spa, 3555 South Ocean Drive, Hollywood, FL 33019, United States. Speakers: Debra A. Cafaro, Chairman, Chief Executive Officer, Member of Executive Committee and Member of Investment Committee.

Ventas, Inc. to Report Q4, 2014 Results on Feb 13, 2015

Ventas, Inc. announced that they will report Q4, 2014 results at 9:00 AM, Eastern Standard Time on Feb 13, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VEN:GR €66.33 EUR +0.076

VEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brookdale Senior Living Inc $37.95 USD -0.21
HCP Inc $42.22 USD +0.04
Health Care REIT Inc $77.57 USD +0.19
Omega Healthcare Investors Inc $40.26 USD -0.28
Senior Housing Properties Trust $22.39 USD -0.08
View Industry Companies
 

Industry Analysis

VEN

Industry Average

Valuation VEN Industry Range
No financial data is available for VEN.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENTAS INC, please visit www.ventasreit.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.